Cho Sukki, Lee Eung Bae
Department of Thoracic and Cardiovascular Surgery, Kyungpook National University, School of Medicine, Daegu, Republic of Korea.
Interact Cardiovasc Thorac Surg. 2010 Aug;11(2):146-9. doi: 10.1510/icvts.2009.226589. Epub 2010 May 3.
This study aimed to investigate the efficacies and complications associated with the 7F catheter inserted in patients with pneumothorax in the emergency room and to compare the results for primary and secondary pneumothorax. From June 2006 to May 2008, 200 patients with primary or secondary pneumothorax treated with a 7F catheter were enrolled. The primary endpoint was the immediate success rate. Success with the 7F catheter was defined as complete or nearly complete lung expansion following insertion without the need for a conventional chest tube or surgical treatment. One hundred fifty-four patients were diagnosed with primary pneumothorax, 38 patients with secondary pneumothorax, and eight patients with iatrogenic pneumothorax. Treatment for 48 of the 200 patients (24.0%) failed; 30 patients were given a conventional chest tube and 18 patients had surgical resections without a conventional chest tube. The failure group included 26 patients (16.9%) with primary, 20 patients (52.6%) with secondary, and two patients (25%) with iatrogenic pneumothorax. The failure rate of patients with secondary pneumothorax was significantly higher than that of patients with primary pneumothorax (P<0.05). We can confirm that the 7F catheter is an effective approach to the treatment of primary pneumothorax, including first, recurrent, and postoperative pneumothorax.
本研究旨在调查急诊室中气胸患者插入7F导管的疗效及并发症，并比较原发性和继发性气胸的治疗结果。2006年6月至2008年5月，纳入200例接受7F导管治疗的原发性或继发性气胸患者。主要终点是即刻成功率。7F导管治疗成功定义为插入后肺完全或接近完全复张，无需放置传统胸管或手术治疗。154例患者诊断为原发性气胸，38例为继发性气胸，8例为医源性气胸。200例患者中有48例（24.0%）治疗失败；30例患者放置了传统胸管，18例患者未放置传统胸管而行手术切除。失败组包括26例（16.9%）原发性气胸患者、20例（52.6%）继发性气胸患者和2例（25%）医源性气胸患者。继发性气胸患者的失败率显著高于原发性气胸患者（P<0.05）。我们可以确认，7F导管是治疗原发性气胸（包括首次、复发性和术后气胸）的有效方法。
